Although glucocorticoid treatment induces muscle atrophy via muscle GRs (18), the contribution of muscle GR signaling to systemic fat accumulation and metabolic derangements such as glucose intolerance has not been well studied. Here, NR3C1 is linked to Glucose intolerance.